Ipamorelin dosing chart (mg to units)
Ipamorelin's library description identifies a growth hormone secretagogue discussed in endocrine literature. PinPoint places it in the peptide category with Limited human research status. A 5 mg supplier-catalog vial supplies the total behind this page's five amount-to-volume examples.
Vial concentration
Water mL is treated as final solution mL in these columns.
| Vial contents | 1 mL water | 2 mL water | 3 mL water |
|---|---|---|---|
| 5 mg | 5 mg/mL20 U-100 units per mg | 2.5 mg/mL40 U-100 units per mg | 1.6667 mg/mL60 U-100 units per mg |
Vial source: PinPoint/Data/CompoundLibrary.swift, line 505, the Ipamorelin entry. One documented amount is available.
Amount to units
Example amounts (arithmetic only, not doses).
| Amount (mg) | 5 mg + 1 mL | 5 mg + 2 mL | 5 mg + 3 mL |
|---|---|---|---|
| 0.1 mg | 2 units | 4 units | 6 units |
| 0.25 mg | 5 units | 10 units | 15 units |
| 0.5 mg | 10 units | 20 units | 30 units |
| 1 mg | 20 units | 40 units | 60 units |
| 2.5 mg | 50 units | 100 units | 150 unitsover one syringe |
Cited amounts
| Amount (mg) and source context | Frequency as stated | Route as stated | 5 mg + 1 mL | 5 mg + 2 mL | 5 mg + 3 mL | Source |
|---|---|---|---|---|---|---|
| 0.2 mgEndpoint of vendor 200–300 microgram combination amount alongside CJC-1295 without DAC. | 2–3 times daily | Subcutaneous | 4 units | 8 units | 12 units | Westwood Biotech, combination protocolSupplier or vendor (last resort)Retrieved 2026-10-05 |
| 0.3 mgEndpoint of vendor 200–300 microgram combination amount alongside CJC-1295 without DAC. | 2–3 times daily | Subcutaneous | 6 units | 12 units | 18 units | Westwood Biotech, combination protocolSupplier or vendor (last resort)Retrieved 2026-10-05 |
How to read this chart
Find the concentration column. Divide the amount by that concentration. Multiply the mL value by 100 for U-100 units. Match the amount units before dividing.
units = amount ÷ (vial mg ÷ water mL) × 100
Amount and volume
One mg equals 1,000 mcg; 100 U-100 units equals 1 mL. Concentration connects amount to volume. Read the full conversion guide.
The two-hour input behind the timeline
For ipamorelin, the stored elimination half-life is two hours. The entry cites a peer-reviewed human study for the reported half-life, rather than presenting an uncited timing value. Two hours is short compared with a full day, so the clock time of a logged event contributes useful detail beyond its calendar date. A level display uses that timestamp to locate a rise and decline within the surrounding schedule. The 5 mg vial calculation has a different purpose: it maps an amount to volume without an elapsed-time component.
A peak parameter below one hour
PinPoint's base ipamorelin parameters include a bioavailability value of 0.85 and a time-to-peak field of 0.33 hours. That decimal hour is approximately 20 minutes. The peak-time field governs a different aspect of the estimate from the two-hour elimination field, so the two numbers are not alternative descriptions of one duration. A recorded event can have a relatively early modeled peak and a longer modeled tail. These are the app's stored inputs for plotting; the chart's concentration columns do not multiply or divide by either value.
The route and frequency metadata
The ipamorelin record lists subcutaneous as its administration route and compounded vial as its form. Once daily, Twice daily, and Three times daily appear in its common-frequency array. Those labels describe separate schedule choices in the library, making individual timestamps relevant when more than one event shares a date. The app stores the amount in mg. Retaining the route, amount, and event time together gives the tracker information that a syringe marking alone cannot provide, even when that marking was calculated correctly.
A tenth of the vial as a worked comparison
The documented ipamorelin package contains 5 mg, and its citation is classified as a supplier catalog. A tenth of those contents is 0.5 mg, the middle row of the example ladder. At 5 mg per mL that portion is 0.1 mL; at 2.5 mg per mL it becomes 0.2 mL. The two volumes correspond to 10 and 20 U-100 units. Both calculations describe the same 0.5 mg portion. The complete ladder also includes 0.1, 0.25, 1, and 2.5 mg to show smaller and larger fractions.
Questions about the conversion
What concentration is Ipamorelin at 5 mg in 1 mL?
5 mg divided by 1 mL is 5 mg per mL. That volume spans 100 U-100 syringe units.
How does 2 mL change the concentration of this Ipamorelin vial?
5 mg divided by 2 mL is 2.5 mg per mL, half the concentration in the 1 mL column.
What does the 3 mL column mean for Ipamorelin?
5 mg divided by 3 mL is approximately 1.6667 mg per mL. The full 3 mL volume corresponds to 300 U-100 units.
How many units is 0.5 mg of Ipamorelin from this vial in 2 mL?
0.5 mg divided by 2.5 mg per mL is 0.2 mL, or 20 U-100 units.
How many units is the 0.2 mg cited amount of Ipamorelin from a 5 mg vial in 2 mL?
The arithmetic is 0.2 mg ÷ 2.5 mg/mL × 100 = 8 U-100 units (0.08 mL). The amount is cited in Westwood Biotech, combination protocol. Endpoint of vendor 200–300 microgram combination amount alongside CJC-1295 without DAC.
Track your calculations in the app
PinPoint for iOS brings vial setup, unit conversion, dose logs, site rotation, and protocol tracking together. Enter vial size and water volume for concentration and syringe units, then log injections with compound, dose, site, and pain level.
Get PinPoint on the App Store